
Wednesday 24 April 2024: 13:00-18:15
Thursday 25 April 2024: 09:00-18:00 - Conference Dinner: 20:00
Friday 26 April 2024: 09:00-16:30
13:00-13:45 |
Check-In |
|
13:45-14:00 |
Opening Ceremony |
|
S1. Molecules Against Cancer (Part 1)chaired by Rino Ragno |
||
|
14:00-14:30 |
Swen Hoelder |
A tricycle journey to in vivo inhibitors and degraders of the oncogenic transcription factor BCL6 The Institute of Cancer Research, UK |
|
14:30-14:45 |
Giuseppe La Regina |
Induction of Ferroptosis by New Pyrrole Tubulin Assembly Inhibitors Sapienza University of Rome, Italy |
|
14:45-15:00 |
Marta Jędrzejczyk |
Triphenylphosphonium salts of salinomycin as antiproliferative agents targeting the mitochondria Adam Mickiewicz University, Poland |
|
15:00-15:15 |
Diana Aleksanyan |
Anticancer potential of Pd(II) pincer complexes derived from thiophosphoryl-functionalized amides Nesmeyanov Institute of Organoelement Compounds, Russia |
|
15:15-15:30 |
Victoria Mora |
EU-OPENSCREEN: an open access initiative in chemical biology to support anti-cancer drug discovery EU-OPENSCREEN ERIC, Campus Berlin Buch, Germany |
|
15:30-15:45 |
Carla Marisa Magalhães |
Synchrotron-Radiation FTIR-Based Investigation of the Anticancer Activity of Metabolic Products of a Marine Bioluminescent System University of Porto, Portugal |
|
15:45-16:15 |
Coffee Break |
|
S1. Molecules Against Cancer (Part 2)chaired by Rino Ragno |
||
|
16:15-16:30 |
Roman Dembinski |
Dicobalt Hexacarbonyl Furopyrimidine Nucleosides with Alkynyl Substituent and their Antiproliferative Activity Oakland University, USA |
|
16:30-16:45 |
Iván Rodríguez-Pampín |
Reprogramming the Immune System using Multi-Target A2AAR-A2BAR Antagonists for Cancer Therapy University of Santiago de Compostela, Spain |
S2. RNA-Targeting Small Molecule Drugs and Degraders (Part 1)chaired by Roman Dembinski |
||
|
16:45-17:15 |
Alessandra Magistrato |
Small-molecule modulators of pre-mRNA splicing IOM at The International School of Advanced Studies, Italy |
|
17:15-17:30 |
Barak Akabayov |
Targeting an RNA hairpin within the ribosomal PTC of M.tuberculosis: AI-Enhanced Molecules for Next-Gen Antibiotics Ben-Gurion University of the Negev, Israel |
|
17:30-17:45 |
Valeria Cavalloro |
(R)-aloesaponol-III-8-methyl-ether as a new hit against neurodegeneration University of Pavia, Italy |
Flash Poster Presentation Sessionchaired by Roman Dembinski |
||
|
17:45-18:15 |
Daniela Rossi |
Recent advances in anticancer therapy: identification of new allosteric modulators of FGF/FGFR system University of Pavia, Italy |
|
Antonio Andújar-Arias |
Discovery and Optimization of a Novel Class of Positive Allosteric Modulators for the Cannabinoid 2 Receptor University of Santiago de Compostela, Spain |
|
|
Ainoa Sanchez Arfelis |
Is It Possible to Degrade C-Myc With Low Affinity Compound - Based Protacs? University of Barcelona, Spain |
|
|
Roberta Listro |
Novel Therapeutic Approaches in Fighting Antimicrobial Resistance: Targeting LsrK in Bacterial Quorum Sensing University of Pavia, Italy |
|
|
Ramona Santini |
Discotic Amphiphile Supramolecular Polymers for Drug Release and Cellular Activation With Light The Institute for Bioengineering of Catalonia, Spain |
|
|
Melania Elettra Vaccari |
Sigma receptor modulators for fighting cancer or neuropathic pain: activity switches by small structural changes University of Pavia, Italy |
|
|
Kinga Czarnota-Łydka |
Triazine-Based Small Molecules as Novel 5-HT6/FAAH Modulators Jagiellonian University, Poland |
|
|
Pooja Sharma |
Repurposing drugs as 30s translation protein inhibitors to overcome MDR resistant bacterial strains: Computational and In vitro approach University of Rajasthan, India |
|
|
Maria Emília Sousa |
Synthesis of Marine-Inspired Cyclopeptide Derivatives to Overcome Multidrug Resistance University of Porto, Portugal |
|
|
Priscila P. Dario |
Knoevengael Adducts From Hydroxychloroquine and 7-chloro-4-aminoquinoline: In Vitro Antiprotozoal Activity Against L. Amazonensis Promastigote Form Federal University of Paraná, Brazil |
|
S3. Medicinal Chemistry Tales (Part 1)chaired by Margherita Brindisi |
||
|
09:00-09:30 |
Arun Ghosh |
Beyond Darunavir – Enhancing Protein Backbone Binding to Combat Multidrug-Resistant HIV-1 Variants Purdue University, USA |
|
09:30-09:45 |
Stefano Tomassi |
Navigating the structure of Cell-Penetrating Nucleopeptides with DNA and RNA Binding Properties University of Naples Federico II, Italy |
|
09:45-10:00 |
Ana Mallo-Abreu |
Novel Protein Aggregation Inhibitors with Nanomolar Antiplasmodial Potency, High Selectivity Index and Favorable DMPK Properties University of Barcelona, Spain |
|
10:00-10:15 |
Javier Sánchez |
Improving Neuropathic Pain Relief: Exploring the Potential of Dual Mechanism Compounds through Soluble Epoxide Hydrolase Inhibition University of Barcelona, Spain |
|
10:15-10:30 |
Mariana Spetea |
Identification and pharmacological characterization of new oxymorphone derivatives as bifunctional mu/delta opioid receptor agonists with antinociceptive efficacy and low-liability profile in mice CMBI at University of Innsbruck, Austria |
10:30-11:00 |
Coffee Break |
|
S3. Medicinal Chemistry Tales (Part 2)chaired by Diego Muñoz-Torrero and Simona Collina |
||
|
11:00-11:30 |
Xiaoguang Lei |
Winner of the 2022 Tu You You Award Peking University, China |
|
11:30-11:45 |
Sveva Pelliccia |
Sustainable Rejuvenation of Triazolo Quinoxalin-4(5H)-One Scaffold Synthesis: Chemistry and Preliminary Antimicrobial Evaluation University of Naples Federico II, Italy |
|
11:45-12:00 |
Anna Sampietro |
New dual sEH-AChE inhibitors with amyloid antiaggregating activity for the treatment of Alzheimer's disease University of Barcelona, Spain |
|
12:00-12:15 |
Maria João Matos |
Propargylamine-Containing Compounds for Neurodegenerative Diseases: Biological Activity, Physicochemical Properties and Docking Studies University of Santiago de Compostela, Spain |
|
12:15-12:30 |
Claudio Viegas Jr. |
Design, Synthesis, and Evaluation of Novel Cinnamic Acid-Based N-Acylhydrazone Hybrids as Neuroprotective Agents Against Parkinson's Disease Federal University of Alfenas, Brazil |
|
12:30-12:45 |
Rino Ragno |
db.3d-qsar.com. The first and unique database of usable 3D QSAR models Sapienza University of Rome, Italy |
12:45-13:00 |
Group Photograph |
|
13:00-14:30 |
Lunch Break & Poster Session |
|
S4. Photopharmacological Approacheschaired by Mariana Spetea |
||
|
14:30-15:00 |
Pau Gorostiza |
Controlling neuronal activity with light: from individual cells to brain waves ICREA at Institute for Bioengineering of Catalonia, Spain |
|
15:00-15:15 |
Laia Josa-Culleré |
Photoswitching HDAC inhibitors for the spatiotemporal targeting of cancer cells with light Institute for Advanced Chemistry of Catalonia, Spain |
|
15:15-15:30 |
F. Javier Pérez-Areales |
Red-light modulated photoswitches for peptide stapling University of Barcelona, Spain |
|
15:30-15:45 |
Giacomo Rossino |
Photoswitchable HuR ligands as an innovative strategy for anticancer agents. University of Pavia, Italy |
15:45-16:15 |
Coffee Break |
|
S3. Medicinal Chemistry Tales (Part 3)chaired by Maria Emilia Sousa |
||
|
16:15-16:45 |
Maria Duca |
Design of multifunctional conjugates for the targeting of non-coding RNAs: anticancer and antimicrobial applications Institute of Chemistry of Nice, Université Côte d'Azur, France |
|
16:45-17:00 |
Noemi Villella |
Discovery of novel and potent human Dihydroorotate Dehydrogenase inhibitor that induces differentiation and apoptosis in Acute Myeloid Leukemia University of Turin, Italy |
|
17:00-17:15 |
Adel Nefzi |
Combinatorial Chemistry: Application of Natural Product-Inspired Diversity-Oriented Synthesis to Accelerate Drug Discovery Florida International University, USA |
|
17:15-17.30 |
Beatriz Büschbell |
Unlocking Novel Chemical Matter from Ultra Large Chemical Spaces for ROCK1 and PKA Inhibitors BioSolveIT, Germany |
|
17:30-17:45 |
Igor Zhukov |
Mechanism of Regulation of Aβ Aggregation by S100B protein in Alzheimer Disease. Analysis interactions S100B with Aβ by 19F NMR Spectroscopy Institute of Biochemistry and Biophysics, Poland |
|
17:45-18:00 |
Aitor Valdivia |
VF-57: targeting the release of the fusion peptide in influenza A virus hemagglutinin University of Barcelona, Spain |
20:00-22:00 |
Conference Dinner |
|
S2. RNA-Targeting Small Molecule Drugs and Degraders (Part 2)chaired by Carmen Escolano |
||
|
09:00-09:30 |
Anna Hirsch |
Dynamic combinatorial chemistry as a powerful hit-identification strategy for challenging targets Helmholtz Institute for Pharmaceutical Research Saarlan, Germany |
|
09:30-09:45 |
Pasquale Linciano |
Advancing RNA Targeting Strategies: Developing of HuR Ligands and Assessing of STD NMR to Evaluate their capability to disrupt HuR-mRNA Interactions University of Pavia, Italy |
|
09:45-10:00 |
Jussara Amato |
Ligand-Based Drug Repurposing Strategy and Multiple Biophysical Techniques Identified Viral Rna G-Quadruplex Binders University of Naples Federico II, Italy |
S4. Photopharmacological Approaches (Part 2)chaired by Claudio Viegas Jr. |
||
|
10:00-10:30 |
Wiktor Szymanski |
Photopharmacology: Towards Light-Controlled Pharmacological Therapy GRIP, University of Groningen, The Netherlands |
|
10:30-10:45 |
Luisa Camerin |
Photoswitchable carbamazepine analogs for non-invasive neuroinhibition in vivo Institute for Bioengineering of Catalonia, Spain |
|
10:45-11:00 |
Xavier Just-Baringo |
Visible Light Operated Antimicrobial Peptides: Towards Selective and Resistance-Free Antibiotics University of Barcelona, Spain |
11:00-11:30 |
Coffee Break |
|
S5. Modulation of Epigenetic Targetschaired by Marçal Pastor-Anglada |
||
|
11:30-12:00 |
Paul Brennan |
Rare Disease Target Discovery with Epigenetic Chemical Probes Centre for Medicines Discovery, University of Oxford, UK |
|
12:00-12:15 |
Simona Barone |
Discovery And Characterization Of A New Potent And Selective Histone Deacetylase 6 Inhibitor Against Triple Negative Breast Cancer University of Naples Federico II, Italy |
|
12:15-12:30 |
Giulio Rastelli |
Targeting Aggressive Prostate Cancer Through HDAC6/HSP90 Dual Inhibitors Based on a 2-Amino-Pyrrolopyrimidine Scaffold University of Modena and Reggio Emilia, Italy |
|
12:30-13:00 |
Carles Galdeano |
First-in-class TET2 activator as a new therapeutic strategy to fight cancer University of Barcelona, Spain |
13:00-14:45 |
Lunch Break & Poster Session |
|
S6. Covalent Drug Discoverychaired by Daniea Rossi |
||
|
14:45-15:15 |
Luc Brunsveld |
Fragment-based drug discovery and beyond for molecular glue identification Eindhoven University of Technology, The Netherlands |
|
15:15-15:30 |
Massimo Serra |
Chemical mannosylation of antigenic elastin-like recombinamers for the development of new glyco-nanovaccine against tuberculosis University of Pavia, Italy |
|
15:30-15:45 |
Franz-Josef Meyer-Almes |
Identification of unprecedented binding sites at the surface of HDAC8 using electrophilic fragments Darmstadt University of Applied Sciences, Germany |
|
15:45-16:15 |
Matthias P. Wymann |
Targeting PI3Kα – Bridging Gaps with Covalent Proximity Scanning and Rapid Target Engagement University of Basel, Switzerland |
16:15 |
Award Ceremony and Closing Remarks |
|